The observational study to investigate serum carnitine level for patients who will receive HCC treatments and liver transplantatio

Not Applicable

Recruiting

• Conditions: Hepatocellular carcinoma Liver transplantation

• Registration Number: JPRN-UMIN000039425
• Lead Sponsor: Kobe University Graduate School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-07
• Last Update Posted: 17 October 2023
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

Patients whom the principal investigator judged as inappropriate for the participation of the study

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To investigate serum carnitine level for patients who will receive HCC treatments and liver transplantation

Secondary Outcome Measures

Name	Time	Method
1) To investigate the factors which correlate with the transition of serum carnitine level. 2) To investigate the factors affecting the transition of serum carnitine level. 3) To investigate the usefulness of serum carnitine as the tumor marker for HCC 4) To investigate the relation with the serum carnitine level and the prognosis.